A Win For NKGen Biotech Inc.
Thu, Oct 17, 2024 at 07:43 PM
NKGen Biotech Inc. (NKGN:NASDAQ) rocketted at $0.7, representing a gain of 154.1%. On Thu, Oct 17, 2024, NKGN:NASDAQ hit a New 2-Week High of $0.7. The stock got featured on our News Catalysts scanner on Tue, Oct 15, 2024 at 10:36 AM in the 'BIOTECH' category. From Thu, Oct 03, 2024, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Thu, May 23, 2024 at $2.19 with a volume of 1M+.
About NKGen Biotech Inc. (NKGN:NASDAQ)
NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat...
Top 10 Gainers:
- Molecular Templates, Inc. (MTEM:NASDAQ), 186.15%
- NKGen Biotech Inc. (NKGN:NASDAQ), 154.08%
- JIADE LIMITED (JDZG:NASDAQ), 136.11%
- Staffing 360 Solutions, Inc. (STAF:NASDAQ), 68.12%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 58.7%
- Notable Labs Inc Ord (NTBL:NASDAQ), 57.02%
- ShiftPixy, Inc. (PIXY:NASDAQ), 53.45%
- Brera Holdings PLC (BREA:NASDAQ), 46.43%
- Samfine Creation Holdings Group Limited (SFHG:NASDAQ), 44.98%
- Talphera Inc Com (TLPH:NASDAQ), 39.34%